Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer
Charli Dominguez(National Cancer Institute), Claudia Palena(National Institutes of Health)
Cited by 164
Related Papers
The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance
|Vaccines|2016|393
Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity
|Journal for ImmunoTherapy of Cancer|2020|96
The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies
|Cell Death and Disease|2013|81